when will tirzepatide become generic In less than three years, Eli Lilly's Trirzepatide globally overtakes Merck's Keytruda — $35 Billion vs $31.8 Billion in 2025. The fastest-growing drug ever. From oncology to obesity,GLP1 era is here now .." Zepbound (Tirzepatide) for Chronic Weight
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10




























